• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺癌患者放射性碘生物动力学的简化评估:一种使用连续外部辐射监测的实用方法

Simplified Assessment of Radioiodine Biokinetics for Thyroid Cancer Patients: A Practical Approach Using Continuous External Radiation Monitoring.

作者信息

Tsai Yao-Kuang, Lin Li-Fan, Cheng Cheng-Yi, Wong Ching-Yee Oliver, Wang Wei-Hsung, Shen Daniel Hueng-Yuan, Su Sui-Lung, Chen En-Shih, Chen Tzai-Yang, Chen I-Feng

机构信息

Department of Nuclear Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei 114202, Taiwan.

Department of Nuclear Medicine, Taichung Armed Forces General Hospital, Taichung 411228, Taiwan.

出版信息

Diagnostics (Basel). 2024 May 14;14(10):1010. doi: 10.3390/diagnostics14101010.

DOI:10.3390/diagnostics14101010
PMID:38786308
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11120101/
Abstract

INTRODUCTION

The biokinetics of radioiodine (RAI) in thyroid cancer patients are complex. This study aims to develop a practical approach for assessing RAI biokinetics to predict patient discharge time and estimate radiation exposure to caregivers.

METHODS

We retrospectively reviewed data from patients with differentiated thyroid carcinoma undergoing RAI treatment. Serial radiation dose rates were dynamically collected during hospitalization and fitted to a biexponential model to assess the biokinetic features: RAI uptake fraction of thyroid tissue () and effective half-life of extra-thyroid tissue (). Correlations with Tc thyroid uptake ratio (TcUR), radiation retention ratio (RR), renal function, and body mass index (BMI) were analyzed.

RESULTS

Thirty-five patients were enrolled. The derived was 0.08 ± 0.06 and was 7.57 ± 1.45 h. Pearson's correlation analysis revealed a significant association between and both TcUR and RR ( < 0.05), while correlated with renal function and BMI ( < 0.05).

CONCLUSION

This novel and practical method assessing RAI biokinetics demonstrates consistency with other parameters and related studies, enhancing the model reliability. It shows promise in predicting an appropriate discharge time and estimating radiation exposure to caregivers, allowing for modifications to radiation protection precautions to follow ALARA principle and minimize the potential risks from radiation exposure.

摘要

引言

甲状腺癌患者体内放射性碘(RAI)的生物动力学较为复杂。本研究旨在开发一种评估RAI生物动力学的实用方法,以预测患者出院时间并估算护理人员的辐射暴露剂量。

方法

我们回顾性分析了接受RAI治疗的分化型甲状腺癌患者的数据。在住院期间动态收集系列辐射剂量率,并将其拟合到双指数模型中,以评估生物动力学特征:甲状腺组织的RAI摄取分数()和甲状腺外组织的有效半衰期()。分析了其与锝甲状腺摄取率(TcUR)、辐射滞留率(RR)、肾功能和体重指数(BMI)的相关性。

结果

共纳入35例患者。得出的为0.08±0.06,为7.57±1.45小时。Pearson相关性分析显示与TcUR和RR均存在显著关联(<0.05),而与肾功能和BMI相关(<0.05)。

结论

这种评估RAI生物动力学的新颖实用方法与其他参数及相关研究具有一致性,提高了模型的可靠性。它在预测合适的出院时间和估算护理人员的辐射暴露剂量方面显示出前景,能够根据“尽可能合理地降低辐射剂量”(ALARA)原则调整辐射防护措施,并将辐射暴露的潜在风险降至最低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9872/11120101/1b23e050f4b7/diagnostics-14-01010-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9872/11120101/1df827f705af/diagnostics-14-01010-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9872/11120101/f03e8d85bf89/diagnostics-14-01010-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9872/11120101/1b23e050f4b7/diagnostics-14-01010-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9872/11120101/1df827f705af/diagnostics-14-01010-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9872/11120101/f03e8d85bf89/diagnostics-14-01010-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9872/11120101/1b23e050f4b7/diagnostics-14-01010-g003.jpg

相似文献

1
Simplified Assessment of Radioiodine Biokinetics for Thyroid Cancer Patients: A Practical Approach Using Continuous External Radiation Monitoring.甲状腺癌患者放射性碘生物动力学的简化评估:一种使用连续外部辐射监测的实用方法
Diagnostics (Basel). 2024 May 14;14(10):1010. doi: 10.3390/diagnostics14101010.
2
Radiation Safety Precautions in (131)I Therapy of Graves' Disease Based on Actual Biokinetic Measurements.基于实际生物动力学测量的格雷夫斯病(131)I治疗中的辐射安全预防措施。
J Clin Endocrinol Metab. 2015 Aug;100(8):2934-41. doi: 10.1210/jc.2015-1682. Epub 2015 Jun 5.
3
Absorbed dose coefficients for pediatric differentiated thyroid cancer patients undergoing radioiodine therapy.接受放射性碘治疗的小儿分化型甲状腺癌患者的吸收剂量系数。
J Radiol Prot. 2024 Feb 7;44(1). doi: 10.1088/1361-6498/ad1fdc.
4
Defining Radioiodine-Refractory Differentiated Thyroid Cancer: Efficacy and Safety of Lenvatinib by Radioiodine-Refractory Criteria in the SELECT Trial.根据放射性碘难治标准定义放射性碘难治性分化型甲状腺癌:SELECT 试验中仑伐替尼的疗效和安全性。
Thyroid. 2017 Sep;27(9):1135-1141. doi: 10.1089/thy.2016.0549. Epub 2017 Aug 14.
5
The feasibility of low-dose oral lithium therapy and its effect on thyroidal radioiodine uptake, retention, and hormonal parameters in various subcategories of hyperthyroid patients: a pilot study.低剂量口服锂盐治疗的可行性及其对各类甲亢患者甲状腺放射性碘摄取、潴留和激素参数的影响:一项初步研究。
Nucl Med Commun. 2016 Jan;37(1):74-8. doi: 10.1097/MNM.0000000000000414.
6
Estimated dose rates to members of the public from external exposure to patients with 131I thyroid treatment.131I 甲状腺治疗患者对公众造成的外照射估计剂量率。
Med Phys. 2015 Apr;42(4):1851-7. doi: 10.1118/1.4915084.
7
Absorbed dose coefficients for adult thyroid cancer patients undergoing radioiodine therapy.成人甲状腺癌患者放射性碘治疗的吸收剂量系数。
J Radiol Prot. 2023 May 25;43(2). doi: 10.1088/1361-6498/acd648.
8
Internal Dose Assessment after 131I-Iodide Misadministration in a Patient With Incompletely Blocked Thyroid Uptake: Personalized Internal Dose Assessment by Estimating Individual-Specific Biokinetics.131I-碘化物误用后患者体内内剂量评估:通过估计个体特异性生物动力学进行个体化内剂量评估。
Health Phys. 2019 Jun;116(6):760-770. doi: 10.1097/HP.0000000000001019.
9
Clinical significance of extra-thyroid Tc-pertechnetate uptake before initial radioiodine therapy for differentiated thyroid carcinoma.分化型甲状腺癌初始碘-131 治疗前甲状腺外 Tc-过锝酸盐摄取的临床意义。
J Int Med Res. 2021 May;49(5):3000605211012667. doi: 10.1177/03000605211012667.
10
Iodine biokinetics and radioiodine exposure after recombinant human thyrotropin-assisted remnant ablation in comparison with thyroid hormone withdrawal.重组人促甲状腺激素辅助残余消融后碘生物动力学和放射性碘暴露与甲状腺激素停药的比较。
J Clin Endocrinol Metab. 2010 Jul;95(7):3283-90. doi: 10.1210/jc.2009-2528. Epub 2010 Apr 14.

引用本文的文献

1
Whole-body effective half-life of radioiodine in children and young adults with papillary thyroid cancer.儿童和年轻乳头状甲状腺癌患者体内放射性碘的全身有效半衰期。
Endocrine. 2025 May;88(2):537-544. doi: 10.1007/s12020-025-04183-1. Epub 2025 Feb 2.

本文引用的文献

1
Implications of recent epidemiologic studies for the linear nonthreshold model and radiation protection.近期流行病学研究对线性无阈模型及辐射防护的启示
J Radiol Prot. 2018 Sep;38(3):1217-1233. doi: 10.1088/1361-6498/aad348. Epub 2018 Jul 13.
2
The role of postoperative Tc-99m pertechnetate scintigraphy in estimation of remnant mass and prediction of successful ablation in patients with differentiated thyroid cancer.术后锝-99m高锝酸盐闪烁扫描在分化型甲状腺癌患者残余肿块评估及成功消融预测中的作用
Nucl Med Commun. 2016 Jun;37(6):640-5. doi: 10.1097/MNM.0000000000000492.
3
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
2015年美国甲状腺协会成人甲状腺结节和分化型甲状腺癌管理指南:美国甲状腺协会甲状腺结节和分化型甲状腺癌指南工作组
Thyroid. 2016 Jan;26(1):1-133. doi: 10.1089/thy.2015.0020.
4
Thyroid cancer: radiation safety precautions in 131I therapy based on actual biokinetic measurements.甲状腺癌:基于实际生物动力学测量的 131I 治疗中的辐射安全预防措施。
Radiology. 2014 Oct;273(1):211-9. doi: 10.1148/radiol.14132234. Epub 2014 Jun 5.
5
First-day iodine kinetics is useful for individualizing radiation safety precautions for thyroid carcinoma patients.首日碘动力学对于个体化甲状腺癌患者的辐射安全防护措施很有用。
Nucl Med Commun. 2013 Dec;34(12):1208-15. doi: 10.1097/01.mnm.0000434308.87736.a5.
6
Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I : practice recommendations of the American Thyroid Association.131I 放射性碘治疗甲状腺疾病患者的辐射安全:美国甲状腺协会的实践建议。
Thyroid. 2011 Apr;21(4):335-46. doi: 10.1089/thy.2010.0403. Epub 2011 Mar 18.
7
Postsurgical thyroid remnant estimation by (⁹⁹m) Tc-pertechnetate scintigraphy predicts radioiodine ablation effectiveness in patients with differentiated thyroid carcinoma.(⁹⁹m)Tc-过锝酸盐闪烁显像术对甲状腺术后残余甲状腺组织的估计预测分化型甲状腺癌患者放射性碘消融的效果。
Head Neck. 2011 Apr;33(4):552-6. doi: 10.1002/hed.21490. Epub 2010 Sep 7.
8
Role of Tc-99m pertechnetate for remnant scintigraphy post-thyroidectomy.术后甲状腺残留组织锝-99m 过锝酸盐闪烁显像的作用。
Clin Nucl Med. 2010 Sep;35(9):671-4. doi: 10.1097/RLU.0b013e3181e9f917.
9
[European consensus on the management of patients with differentiated carcinoma of the thyroid from follicular epithelium].[欧洲关于滤泡上皮来源的分化型甲状腺癌患者管理的共识]
Vestn Khir Im I I Grek. 2008;167(1):52-6.
10
The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103.国际放射防护委员会2007年建议。ICRP第103号出版物。
Ann ICRP. 2007;37(2-4):1-332. doi: 10.1016/j.icrp.2007.10.003.